^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Malignant Pleural Mesothelioma |
| Regimen: | GC (cisplatin + gemcitabine) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Other acceptable first-line combination chemotherapy options recommended by NCCN include:...2) gemcitabine/cisplatin...
